ArticleFrontiers in oncology2020

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients.

Yanwei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.